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Pemphigus is a severe, blistering disease of the skin and mucous membranes. There 
is  loss  of epidermal  cohesion manifested  clinically  by  induction  of intraepidermal 
blisters  and  erosions  with  mechanical  trauma  (Nikolski's sign).  Biopsies of lesional 
skin reveal rounding up of epidermal  cells  with loss of epidermal cell adhesion: this 
pattern is referred to as acantholysis. Two major types of pemphigus are distinguished 
clinically and histopathologically. Pemphigus vulgaris exhibits extensive erosions and 
the vesicles  form just above the basal layer of epidermal cells.  In contrast, pemphigus 
foliaceous has very shallow blisters that appear in the more superficial granular layer 
of the epidermis. 
In 1964, Beutner and Jordan (1) demonstrated that serum from pemphigus patients 
contained autoantibodies that bound to an intercellular substance of skin and mucosa. 
Skin  biopsies  revealed  in  vivo  deposition  of autoantibodies  in  the  epidermis  of 
pemphigus  patients  (2).  Recently,  immunoflorescence techniques  have  shown  that 
pemphigus  antibody  binds  to  the  surface  of mouse  epidermal  cells  (3-5),  human 
epidermal ceils  (5, 6), squamous cell carcinoma lines (7, 8), and a cervical carcinoma 
cell line (K. Singer, unpublished results). 
Michel  and  Ko  (9)  reported  that  incubation  of pemphigus antibody with  organ 
cultures of normal human skin resulted in histologic changes identical to those seen 
in biopsies of skin from pemphigus patients.  Schiltz and Michel (10) showed that the 
IgG fraction of serum was responsible for loss of cellular adhesion in a  complement- 
independent manner. 
Our laboratory  (3)  presented  evidence that  a  proteinase  was  responsible  for the 
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acantholysis found in pemphigus. Incubation of cultured mouse epidermal cells with 
pemphigus antibody resulted in detachment of cells from the culture vessel. Detach- 
ment  was  blocked  by  the  addition  of  the  proteinase  inhibitors  soybean  trypsin 
inhibitor  and  alpha2-macroglobulin.  These  data  suggested  that  after  binding  of 
pemphigus antibody to the surface of epidermal cells, a proteinase was activated that 
was involved in toss of cell adhesion.  Using skin explant cultures, Morioka et al. (11) 
confirmed a  role for proteinases in acantholysis. They reported that the acantholysis 
observed  after  incubation  of  normal  skin  with  pemphigus  IgG was  inhibited  by 
soybean trypsin inhibitor and pepstatin A, inhibitors of serine and carboxyl protein- 
ases, respectively. 
Plasminogen activators (PA) 1 are serine proteinases that catalyze the conversion of 
plasminogen  to  plasmin.  Recently,  the  role  of  PA  in  the  regulation  of localized 
proteolysis within the microenvironment of cells has received much attention. A wide 
variety of normal  vertebrate adult  and  embryonic cells  produce  PA  under  certain 
circumstances,  and  this  production  is  highly  regulated  (for review see  ref.  12-14). 
Included  among  these  cells  are  macrophages  (15,  16),  granulocytes  (17),  ovarian 
granulosa cells  (18,  19),  fibroblasts  (20-24),  trophoblasts  (25), endothelial  cells  (26), 
and mouse epidermal cells (27).  Reich (12)  has suggested that the significance of this 
highly  regulated  enzyme production  is  that  PA  is  of critical  importance  in  tissue 
remodeling and cell migration.  PA levels are elevated in primary malignant tumors 
(28),  in cells transformed by oncogenic viruses  (20,  21,  29), and in cells treated with 
tumor promoters (22, 30-32). PA levels may be modulated by agents such as hormones 
(17,  25), retinoids  (33,  34), and lectins (31). 
Recently,  Becker et al.  (35)  reported  that  IgG that  binds  to cell surface antigens 
can modulate  PA production  in  a  variety of cell types.  Their results  suggested the 
possibility that PA might be the serine proteinase stimulated in epidermal cells after 
the  binding  of pemphigus  autoantibody.  The  studies  presented  here  indicate  that 
binding  of pemphigus  autoantibody  to  human  epidermal  cells  results  in  elevated 
levels  of  both  cell-associated  and  secreted  PA,  and  that  PA  is  involved  in  the 
pathogenesis of pemphigus. 
Materials and Methods 
Chemicals  and  Other  Materials.  Chemicals and  supplies  were obtained from the  following 
sources:  Hanks' balanced salt  solution,  fetal  calf serum  (FCS),  dog serum, and  antibiotic/ 
antimycotic from Gibco Laboratories, Grand Island Biological  Co., Grand Island, NY;  Dul- 
becco's modified  Eagle's medim'n  (DME)  from  B  & B  Research,  Baltimore,  MD;  trypsin, 
mitomycin C, bovine fibrinogen,  dexamethasone, Triton X-100, casein, bovine serum albumin, 
aprotinin, and lima bean trypsin inhibitor (LBTI) from Sigma Chemical Co., St. Louis, MO; 
hydrocortisone and cycloheximide from Calbiochem-Behring Corp., La Jolla, CA; cholera toxin 
and  Tris  from Schwarz/Mann,  Orangeburg,  NY;  Coomassie Blue,  Bromphenyl  Blue,  and 
sodium  dodecyl  sulfate  from  Bio-Rad  Laboratories,  Richmond,  CA;  lysine-Sepharose  and 
protein A-Sepharose  from Pharmacia Fine Chemicals, Piscataway, N  J; cluster 6 culture dishes 
from Costar, Data Packaging, Cambridge, MA; Linbro muhiwell plates from Flow Laborato- 
ries, McLean, VA; microfuge tubes from Walter Sarstedt, Inc., Princeton, N  J; sodium heparin 
from Upjohn  Co.,  Kalamazoo, MI;  epidermal  growth  factor from Collaborative Research, 
Waltham, MA; Millex 0.45-/un filters from Millipore Corp., Bedford, MA; urokinase reference 
standard from Leo Pharmaceutical Industries, Ballerup,  Demnark. 
i Abbreviations used in this paper: DME, Dulbecco's  modified Eagle's medium; FCS, fetal calf serum; LBTI, 
lima bean trypsin inhibitor; PA, plasminogen activator; PBS, phosphate-buffered saline; Pf, pemphigus 
foliaceous; Pv, pemphigus vulgaris; SDS, sodium dodecyl sulfate; TCA, trichloroacetic acid. HASHIMOTO  ET AL.  261 
Epidermal Cell Cultures.  Human epidermal cells from newborn foreskins were cultured using 
a modification of the technique of Rheinwald and Green (36). Foreskins were obtained within 
3  h  of circumcision and incubated briefly in antibiotic- and antimycotic-containing tissue 
culture medium. After removal of fatty tissue, the foreskin was placed epidermal side down in 
0.25% trypsin in Hanks' balanced salt solution and incubated at 4°C for 18-24 h. The epidermis 
was then easily removed from the dermis and teased with forceps  to obtain a cell suspension. 
Cellular debris was allowed to settle and the cells remaining in suspension were plated into the 
wells of Costar cluster 6  tissue culture dishes (1-2 ×  105 cells/8 cm  2 well),  which had been 
seeded  with  mitomycin C-treated  (15  #g/ml, 2  h,  37°(3)  mouse 3T3  fibroblasts (CCL  92; 
American Type Culture Collection, Rockville, MD).  Epidermal cells  were  grown in DME 
supplemented with FCS to a final concentration of 20%, 20 ng/ml epidermal growth factor, 0.4 
#g/ml hydrocortisone, 10  -x° M  cholera toxin,  100 U/ml penicillin, 100/zg/ml streptomycin, 
and 0.25/zg/ml fungizone (antibiotic/antimycotic).  Cultures were confluent within 3-5 wk. All 
experiments were performed on cell cultures that had reached confluence. 
Harvest  of Conditioned Medium  and  Cell  Lysates.  After  reaching confluence, the  cells  were 
incubated overnight with DME containing  20% FCS and no other additives. The cultures were 
then incubated with DME (1 ml/well) with or without IgG. 24 h later this conditioned medium 
was harvested, centrifuged at 6,500 g for 5 min, and assayed for extracellular PA activity using 
the fibrin plate method described below. The cells were then washed three times with phosphate- 
-buffered saline (PBS),  pH  7.3, and treated with 0.5% Triton X-100 in 0.01 M  Tris-HC1, pH 
7.8, for 5 min at 4°C (1  ml/well). The wells were scraped with a rubber policeman and the 
contents were transferred to a  1.5-ml microfuge tube and centrifuged at 6,500 g for 5 min. The 
supernatant (cell lysate) was assayed to determine cell-associated PA activity. The wells used in 
a single experiment contained cells originating  from the same foreskin. Preliminary  experiments 
documented that, at confluence, the cell number in different wells from a single foreskin varied 
by <15% (data not shown). Cell numbers were not routinely determined in each well because 
it was desirable to obtain cell lysates from each well. Determination of cell numbers would have 
required trypsinization, which would have altered cell viability and introduced trypsin-related 
artifacts. 
IgG Preparations.  Preparations of pemphigus vulgaris  (Pv)  IgG  from  two  patients were 
studied. The source of Pv IgG used in the majority of experiments was  the kind gift  of Dr. 
Joseph McGuire, Department of Dermatology, Yale University Medical Center. The patient 
was a 49-yr-old female with a 3-yr history of Pv, who at the time of plasma collection had a 
flare up of her disease.  Her serum had an indirect immunofluorescence pemphigus antibody 
titer of 1:320. IgG preparations from three patients with pemphigus foliaceous (Pf) were also 
studied. The results presented here were obtained primarily from serum and plasma collected 
from an 18-yr-old male patient at Duke University Medical Center. Clinical examination and 
histological examination were consistent with a diagnosis of Pf. These findings were confirmed 
by immunofluoreseent examination of his skin biopsy, which showed deposition of IgG in the 
intercellular  spaces of the epidermis. Indirect immunofluorescence  revealed a serum pemphigus 
antibody titer of 1:80. None of the patients studied had received therapy for their disease at the 
time of serum or plasma collection. Serum and plasma were also collected from normal donors. 
IgG was prepared from patient serum and plasma and from normal serum and plasma by 
affinity chromatography. After single-step isolation of IgG using the standard technique of 
affinity purification on Staphylococcal protein A-Sepharose (37), we detected plasminogen as 
a  contaminant in IgG preparations  (38). Consequently, IgG was  routinely isolated  free  of 
plasminogen by sequential column chromatography on lysine-Sepharose, which binds plasmin- 
ogen  (39), followed  by protein A-Sepharose.  All IgG preparations used  in the experiments 
described  were  isolated  in  this  manner.  Briefly,  the  serum  was  diluted  twofold  in 0.1  M 
phosphate  buffer,  pH  7.0, and  applied  to  a  column  of  lysine-Sepharose that  had  been 
equilibrated with the same buffer. The lysine-Sepharose column was connected directly to a 
column of protein A-Sepharose equilibrated with the starting buffer. After the sample had run 
from the lysine-Sepharose column into the protein A-Sepharose column, the latter was washed 
extensively with 0.1 M  phosphate buffer, pH 7.0, and the IgG was eluted with 0.1 M glycine- 
HCI in 0.15 M  NaCI, pH 3.0. When IgG was prepared from plasma, 5 U/ml sodium heparin 
was included in all buffers. Fractions containing IgG were pooled and neutralized using 1 M 262  PEMPHIGUS-STIMULATED PLASMINOGEN ACTIVATOR ACTIVITY 
Tris.  Protein concentrations were determined and adjusted to 8-10 mg/ml. The IgG prepara- 
tions were dialyzed against  DME and  filter-sterilized using Millex 0.45-/Lm  filters. IgG prepa- 
rations  isolated in  this manner were incubated  with urokinase  and  assayed  by the lzsI-fibrin 
plate assay described below to confirm that  the immunoglobulin was free of plasminogen. 
PA Assay.  PA was  assayed  using  multiwell culture  dishes  coated  with  125I-fibrin.  Bovine 
fibrinogen,  free  of plasminogen,  was  prepared  according  to  the  method  of Laki  (40)  and 
Mosesson  (41)  and iodinated using chloramine T  (42).  12~I-fibrin-coated muhiwell dishes were 
prepared  according to Strickland  and  Beers  (19).  Each  well  (surface  area  2  cm  2)  was coated 
with 25 #g ~zsI-fibrinogen (~4,000 cpm//Lg). Conversion of fibrinogen to fibrin was accomplished 
by  a  2-h  incubation  at  37°C  with  DME supplemented  with  5%  plasminogen-depleted  fetal 
bovine serum. Each well was washed twice with PBS. Immediately before assay, the wells were 
washed with 0.1  M  Tris-HCl, pH 8.1. The reaction mixture contained 50 #1 of samples  (either 
cell lysates or conditioned medium)  and  1.2 p.g of dog plasminogen, purified from dog serum 
(39)  in a  total volume of 300/~i of 0.1  M  Tris-HC1, pH 8.1. The dishes were incubated  for 60 
min at 37°C, after which the supernatant  was collected and the release of 12SI-labeled  peptides 
from the '2~I-fibrin was quantitated using an LKB model 1270 RackGamma II gamma counter 
(LKB Instruments,  Inc., Turku,  Finland). 
PA activity in  conditioned  medium  and  cell lysates  was  compared  with  the  activity of a 
standard preparation of human urokinase measured on the same day. In each assay, a standard 
curve of PA activity was generated over a  range of 1.6-25  Ploug milliunits (mU) of urokinase 
activity.  All samples  were  diluted  to  fall within  the  linear range  of the standard  curve.  All 
assays were performed in duplicate and  duplicates  varied by __.10%. The PA activity in each 
sample was computed from the standard curve using the RackGamma radioimmunoassay data 
reduction system. 
Because the number of cells in confluent wells originating from the same foreskin differed by 
~15%, the PA activity in the samples was expressed as units of activity per well. Extracellular 
activity was expressed as Ploug milliunits per milliliter conditioned medium collected from one 
well of a Costar cluster 6 plate (surface area 8 cm2). Cell-associated PA activity is expressed as 
Ploug milliunits per milliliter cell lysate extracted from one well. 
Skin  Explant  Cultures.  Skin  explants  were cultured  by  the method  of Morioka et  al.  (11). 
Skin  was  obtained  aseptically  after  face  and  neck  lift  surgery,  reduction  mammoplasty,  or 
laparotomy. After removal of fatty tissue, the skin was cut into pieces ~3 X  3 ram. The pieces 
of skin were placed dermis-side down on paraffin-rimmed lens paper rafts and floated on  1 ml 
of tissue culture medium with or without IgG and/or plasminogen and proteinase inhibitors. 
After appropriate  incubation,  the skin was processed for tissue sectioning, stained with hema- 
toxylin and eosin and observed microscopically using a  Zeiss universal microscope (Carl Zeiss, 
Inc., New York). 
Electrophoretic Analysis  of PA.  The  eleetrophoretic  analysis  of epidermal  cell  PA was  per- 
formed  by  the  method  of Vetterlein  et  al.  (43).  Conditioned  medium  was  collected  from 
cultured  epidermal  cells incubated  with  or without  pemphigus  IgG.  Samples collected from 
cells treated with IgG were preabsorbed  with protein A  Sepharose  (0.9 ml sample plus 0.1  ml 
protein A Sepharose, 4°C, 2 h) to remove the IgG. The samples were then dialyzed to a buffer 
of 0.06 M  Tris, pH 6.8 containing 2.3% sodium dodecyl sulfate (SDS), 10% glycerol, and 0.005% 
Bromphenyl  Blue.  Electrophoresis  was  carried  out  in  slab  gels  using  0.1%  SDS,  a  12.5% 
polyacrylamide running gel, a 5% polyacrylamide stacking gel, and the Laemmli buffer system 
(44,  45).  The gel was removed from the glass plates, agitated  in 2.5% Triton X-100 in 0.1  M 
Tris-HC1, pH 8.1, at 22°C for  1 h, and each lane was cut into 2-ram slices. Each gel slice was 
assayed for PA activity in the lz~I-fibrin plate assay described above. 
Assay for  Cathepsin  D  Using  [all]Hemoglobin  as  Substrale.  Jail]Hemoglobin  was  prepared 
according to Levine et al. (46).  5 ~1 of sodium acetate buffer (1.2 M, pH 7.2), 5/.tl of water, and 
30/~1 of sample were incubated at  37°C with 20/~1 of [3H]hemoglobin  (~300,000  cpm) in 0.4- 
ml polypropylene microfuge tubes  for 2 h. After incubation,  40 ~1 of a  50 mg/ml solution of 
bovine serum  albumin  was  added  to each  tube as carrier protein.  100 ~1 of a  solution of 6% 
trichloroacetic acid (TCA) was added to each tube and the resulting precipitate was pelleted at 
6,500 g in a microfuge.  100 ~1 of the supernatant  was removed from each tube and counted in HASHIMOTO  ET  AL.  263 
an  Intertechnique liquid  scintillation  counter (Intertechnique,  Zurich,  Switzerland).  In this 
assay, 1/,g/ml pepsin caused the release of 5,000 cpm of 3H-labeled TCA-soluble peptides. 
Results 
Pemphigus IgG Stimulates Extracellular and Cell-associated PA.  Confluent cultures of 
human epidermal cells were incubated for 24 h with various concentrations of Pf IgG, 
Pv IgG, or normal human IgG. The conditioned medium and cell lysates were then 
assayed  for  PA  as  described  above  (Fig.  1).  These  data  are  pooled  from  several 
different experiments and are expressed as percent of control. Production of PA was 
IgG dose dependent. Incubation of epidermal cells with normal human IgG resulted 
in a  slight increase (1.7-fold) in extracetlular PA at all concentrations tested and no 
increase in cell-associated PA. Incubation of epidermal cells with Pf IgG resulted in 
a  10-fold increase in extracellular PA and a 5-fold increase in cell-associated PA. The 
stimulation  of both extracellular  and  cell-associated  PA reached  a  maximum at  2 
mg/ml. At higher concentrations of IgG, less stimulation was observed. Incubation of 
epidermal cells  with Pv IgG resulted in a sevenfold increase in extracellular PA and 
a sixfold increase in cell-associated PA. The stimulation of both extracellular and cell- 
associated PA by Pv IgG reached a maximum at 0.5 mg/ml IgG. In other experiments, 
the stimulation of PA by 0.25 mg/ml of Pv IgG was not as great as that seen with 0.5 
mg/ml (data not shown). By adding IgG to samples of conditioned medium collected 
from cells  incubated with  stimulatory concentrations of IgG, we observed that  the 
higher concentrations of IgG did not inhibit the fibrin plate assay (data not shown). 
We  also  tested  one  additional  Pv  IgG  preparation  and  two  additional  Pf  IgG 
preparations. All three stimulated PA in epidermal cells in a dose-dependent manner 
(data not shown). 
Fig. 2 shows the kinetics of PA stimulation by an optimal concentration of Pf IgG 
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FIG.  1.  Stimulation of PA production by pemphigus IgG. Confluent cultures of human epidermal 
cells were incubated with various concentrations of normal human IgG (i), Pv IgG (&), or Pf IgG 
(O)  for 24  h  at  37°C.  Conditioned  medium was collected  and extracellular PA was quantitated 
using the 12sI-fibrin  plate assay as described in Materials and Methods (panel A). Cell lysates were 
prepared using Triton X-100 and cell-associated PA was quantitated (panel B). 264  PEMPHIGUS-STIMULATED  PLASMINOGEN  ACTIVATOR ACTIVITY 
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FIG.  2.  Time course ofpemphigus IgG stimulation of PA production. Confluent cultures of human 
epidermal cells were incubated with normal human IgG (2 mg/ml)  (A), or Pf IgG (2 mg/ml)  (0) 
for 6-24 h at 37°C. Extracellular (panel A) and cell-associated (panel B) PA was quantitated  using 
the 125I-fibrin plate assay. 
(2 mg/ml).  By 6  h, extracellular  PA in cultures  incubated with Pf IgG had risen  to 
200 mU/ml, or approximately  four times that of the cultures incubated with 2 mg/ 
ml normal human IgG. By  12 h, the extracellular  PA levels had risen slightly in the 
Pf cultures but remained the same in the presence of normal IgG. Between  12 and 24 
h  there was a  dramatic increase in the extracellular  PA in the presence of Pf IgG to 
1,600  mU/ml  or  ~10  times  that  in  cultures  treated  with  normal  IgG  for  24  h. 
Maximum  levels of cell-associated  PA were reached somewhat earlier.  By 6 h  about 
three  times  more cell-associated  PA was detected  in  Pf IgG-treated cultures  as that 
found  in  normal  IgG-treated  cultures.  By  12  h,  70  mU/ml  cell-associated  PA was 
detected  in  Pf IgG-treated  cultures,  more  than  nine  times  that  detected  in  normal 
IgG-treated cultures.  The amount of cell-associated PA rose only slightly between  12 
and 24 h, the time during which a dramatic increase in extracellular PA was observed. 
Antibody Stimulation of PA  Is  Not Associated with Release of Lysosomal Enzyme Activ- 
ity.  We  have  documented  in  previous  studies  (3,  6)  (using  trypan  blue  exclusion, 
retention  of ~lCr,  and  incorporation  of radiolabeled  amino  acids  into  protein)  that 
pemphigus  antibody  in  the  absence  of complement  is  not  cytotoxic  for  human  or 
mouse  epidermal  cells,  or  for  a  human  cervical  carcinoma  cell  line  (unpublished 
results).  It  was  important  to  determine  whether  the  increased  enzyme activity  we 
observed is related to cell damage undetected by the above methods or to regurgitation 
of lysosomal contents during endocytosis. The conditioned medium was assayed for 
cathepsin  D  as a  marker  for the release  of Iysosomal enzymes (46).  Epidermal  cells 
were incubated for 24 h  with IgG preparations at various concentrations up to 8 mg/ 
ml  and  the  medium  was  then  tested  for  the  ability  to  hydrolyze  [3H]hemoglobin 
(Table I). Medium from cells incubated with 8 mg/ml IgG had slightly higher enzyme 
activity  than  that  from  cells  incubated  without  IgG.  Medium  collected  from  cells 
incubated with 0.5 mg/ml IgG, which is the optimum for PA stimulation, hydrolyzed 
hemoglobin  to  the  same  extent  as  that  collected  from cells  incubated  without  IgG. 
We conclude that the antibody-mediated stimulation of PA activity is not related to 
cell damage and is not accompanied by a generalized secretion of lysosomal enzymes. 
Pemphigus Antibody-induced PA Stimulation Requires Protein Synthesis.  Epidermal  cells 
were  incubated  for  12  h  with  Pf IgG in  the  presence  of various  concentrations  of 
cycloheximide  (Fig  3).  20  /~g/ml  cycloheximide  inhibited  extracellular  and  cell- 
associated  PA  by  95  and  90%,  respectively.  This  concentration  of cycloheximide HASH1MOTO  ET  AL. 
TABLE  [ 
Hydrolysis of/~H]Hemoglobin  by Conditioned Medium from Human 
Epidermal Cells Incubated with Pv IgG 
]g,G  ~H peptides released* 
mg/ml  cpm 
8  1,316 _+ 78~: 
4  1,093 -+ 46 
2  781  ___ 58 
1  740 ___ 95 
0.5  920 _.+ 26 
0  913 _+ 68 
* 5,000 cpm were released in the presence of 1 gg/ml pepsin. 
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FI~.  3.  Inhibition  by  cyeloheximide  of pemphigus  IgG-stimulated  PA  production.  Confluent 
cultures of human epidermal cells were incubated for  12 h  at 37°C  with Pf IgG (2 mg/ml)  in the 
presence of various concentrations  of cycloheximide.  Extracellular  (0)  and cell-associated  (A)  PA 
were quantitated using the x2~I-fibrin plate assay. Control  values  in the presence  ol  r antibody but 
absence of cyclohexirnide were 685 mU/ml in cell lysates and 2,306 mU/ml in conditioned medium. 
inhibited  incorporation  of [ass]methionine  into proteins  by  82%  (data  not  shown). 
These  data  confirm  that  intact,  metabolically  active  cells  are  required  for  the 
stimulation of PA by pemphigus IgG. 
Inhibition by Dexamethasone of Pf IgG Stimulation of PA.  Epidermal  ceils were incu- 
bated  for 24  h  in  the presence of Pf IgG  and  various  concentrations  of the steroid 
dexamethasone  (Fig. 4). At  ~0  -~° M, extracel]u~ar PA activity was inhibited by 60%. 
At  I0  -s M, 95% inhibition of antibody-induced  PA was achieved.  Stimulation of PA 
production by cells treated with lectins (31) and phorbol esters (30, 31), as well as by 
thioglycollate-stimulated  macrophages  (15), has been reported to be inhibited by the 
same  concentrations  of steroids.  The  inhibitory  concentrations  of dexamethasone 
approximate those used in the clinical treatment of pemphigus. 
Electrophoresis of Antibody-stimulated PA.  Two major types of human  PA are distin- 
guished both biochemically and immunologically. The "urokinase type" has a molec- 
ular weight of 52,000-55,000,  whereas the "tissue factor type" has a molecular weight 
of 68,000-74,000  (23,  26, 43).  Samples of conditioned medium  from cells incubated 
with or without pemphigus IgG were analyzed for PA activity after electrophoresis on 
SDS polyacrylamide gels. The electrophoretic profile of enzymatic activity indicated 
that  the  major  peak  of  PA  activity  secreted  by  unstimulated  cultured  human 
epidermal cells is of a molecular weight of ~55,000  (Fig. 5 A). A trailing of enzymatic 266  PEMPHIGUS-STIMULATED  PLASMINOGEN  ACTIVATOR  ACTIVITY 
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Fro.  4.  Inhibition  by  dexamethasone of pemphigus IgG-stimulated  PA  production.  Confluent 
cultures of human epidermal cells were incubated for 24 h at 37°C in the presence of Pf IgG (2 rag/ 
ml) in the presence of various concentrations of dexamethasone. Extrace|lular PA (0) was quanti- 
tated  using the  ~z~I-fibrin  plate  assay. Control  value in the absence of dexamethasone was  1,576 
mU/ml. 
activity was seen at higher molecular weights. The small peak of activity at  36,000 
mol  wt  is  probably  a  degradation  product  of the  urokinase  type  PA,  as  it  also 
appeared when purified urokinase was electrophoresed as a standard. The electropho- 
retic profile of conditioned medium from cells treated with Pv IgG (Fig.  5 B) or Pf 
IgG  (Fig.  5C)  was  not  different  from  untreated  cells.  These  data  suggest  that 
pemphigus antibody stimulates the production of PA normally produced by cultured 
human epidermal cells. 
Skin Explants.  To investigate the role of antibody-induced increases in PA on the 
loss of epidermal cohesion, skin explant experiments were performed in the presence 
or  absence  of pemphigus  IgG,  human  plasminogen,  and  a  variety  of proteinase 
inhibitors.  When  normal  human  skin  was  incubated  for 48  h  with  IgG  from  Pv 
patients (4 mg/ml), histologic changes resembling Pv occurred (Fig. 6A). The onset 
of these changes  appeared  to be hastened by the inclusion of human  plasminogen 
(200 /~g/ml);  however,  a  strict  dependence  upon  exogenous plasminogen  was  not 
demonstrated (data not shown). No acantholysis was seen in skin explants incubated 
with Pf IgG (4 mg/ml)  (Fig. 6 B); however, when human plasminogen  (200 ffg/ml) 
was included along with Pf [gG (4 mg/ml), acantholysis in the upper epidermis was 
consistently observed (Fig. 6C). No acantholysis was seen in explants incubated with 
human  plasminogen  alone  (200 ffg/ml)  (data  not  shown).  When  aprotinin,  which 
inhibits  plasmin  but  not  PA  (47),  was  included  with  Pf IgG  and  plasminogen, 
production of acantholysis was  inhibited  (Fig. 6D).  Identical results were obtained 
using LBTI, which also inhibits plasmin but not PA (47).  Both aprotinin and LBTI 
were  also  able  to  inhibit  acantholysis  in  explants  incubated  with  Pv  IgG  and 
plasminogen (data not shown). In an effort to further implicate plasmin as having a 
role in acantholysis, skin explants were incubated with plasmin. Acantholytic changes 
were not observed in explants incubated with 3 Sigma U/ml. At higher concentrations, 
the plasmin was toxic to the explants. It is possible that activation of plasminogen by 
antibody-induced PA results in high,  localized concentrations of plasmin  that  were 
not achieved when explants were incubated with plasmin. 
Discussion 
Binding of pemphigus  autoantibody to epidermal cells stimulated  both secreted 
and cell-associated PA in a  time- and dose-dependent manner. The increase in  PA HASHIMOTO ET  AL.  267 
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Fro. 5.  Electrophoretic  profile  of PA  activity in  conditioned  medium  collected  from human 
epidermal cells incubated at 37°C. (A) without IgG, (B) with Pv IgG (1 mg/ml), (C) with Pf lgG 
(2 mg/ml). 1.5-2.5 Ploug units/nl of urokinase equivalent  activity were applied to each lane of a 
slab 12.5% polyacrylamide  gel and electrophoresed. The gel was agitated in 2.5% Triton X-100 for 
1 h  at 22°C  and each  lane was sliced into  2-ram slices. The PA activity in each  gel slice was 
quantitated using the 12sI-fibrin  plate assay. 
was not due to cytotoxicity and was not  accomplished by a  generalized secretion of 
lysosomal enzymes.  Stimulation of PA after interaction of pemphigus antibody and 
epidermal cells was  dependent  upon  protein synthesis and was  prevented by dexa- 
methasone. The molecular species of PA stimulated by both Pv and Pf IgG appeared 
to be the same as that found in cultured human epidermal cells not treated with ]gG, 
and the major peak of PA activity co-migrated in SDS polyacrylamide gels with the 
high-molecular-weight band of urokinase (~55,000). 
Explants  of  human  skin  incubated  with  plasminogen  and  Pf  IgG  underwent 
acantholytic changes identical to those found in biopsies of Pf patients. Acantholysis 
was inhibited by aprotinin and LBTI. Skin explants incubated with Pv IgG showed 
histological changes  identical  to  those  seen  in  patients  with  Pv.  The  inclusion  of 
plasminogen  hastened  the onset of acantholysis in skin explants incubated with  Pv 268  PEMPHIGUS-STIMULATED  PLASMINOGEN ACTIVATOR ACTIVITY 
FIG. 6.  Explants  of normal human skin were incubated for 48 h at 37°C with (A) Pv IgG (4 mg/ 
ml); (B) PfIgG (4 mg/ml); (C) PfIgG (4 mg/ml) plus plasminogen (200 ~g/ml); (D) PfIgG (4 mg/ 
ml), plasminogen (200 ~g/ml), aprotinin  (a total of 60 trypsin inhibitory units was added in doses 
of 20 trypsin inhibitory units at 0 time, 20 h, and 30 h). X 600. 
IgG.  This  observation  is  consistent  with  a  recent  report  by Isseroff and  Rifkin  (48), 
who  found  that  plasminogen  was  preferentially  deposited  on  the  basal  layer  of 
epidermis.  In organ culture experiments  using Pv IgG, exogenously added plasmino- 
gen might not be necessary if plasminogen is already present on the basal cells of the 
epidermis. 
The results presented  here provide evidence for autoantibody-mediated  regulation 
of a  specific disease  process  by activation  of proteolytic enzymes.  Our data  support 
the following molecular mechanism for the autoimmune disease pemphigus.  Binding 
of pemphigus  autoantibody  to  the  surface of human  epidermal  cells  stimulates  the 
production of PA, In the presence of plasminogen, the increased levels of PA result in 
an  increased  conversion of plasminogen  to plasmin.  Plasmin  is  then  responsible  for 
loss of cellular adhesion, probably by degradation of cell surface molecules responsible 
for cell-cell  adhesion  within  the  epidermis.  The  plasmin-induced  dissolution  of the 
intercellular  matrix results in acantholysis, which is the hallmark of pemphigus. HASHIMOTO ET AL.  269 
The significant mortality from pemphigus was greatly reduced when corticosteroid 
therapy became available (49). Corticosteroids in high doses rapidly and dramatically 
reverse blister formation in pemphigus. In our experience, high-dose methyl prednis- 
olone  pulse  therapy  resulted  in  clearing  of blisters  within  48  h  (G.  S.  Lazarus, 
unpublished  results).  Pemphigus  antibody  titers,  however,  drop  significantly  only 
after 2-4 mo of steroid therapy, and some patients become clinically free of disease 
while still  possessing an  antibody titer  (50).  The data  presented in  this report are 
compatible with the hypothesis that corticosteroids act by inhibiting antibody stim- 
ulation of proteinase activation. 
Summary 
Binding of anti-cell surface pemphigus autoantibodies to cultured human epidermal 
cells stimulates synthesis and secretion of plasminogen activator (PA). Increases in PA 
activity were detected within 6 h of the addition of  IgG and stimulation was dependent 
upon IgG concentration. Stimulation of PA activity was inhibited by cycloheximide, 
which  indicates  that  synthesis of protein  was  necessary.  Pharmacological  doses  of 
dexamethasone also prevented IgG-induced stimulation of PA.  Electrophoretic pro- 
files of PA secreted by cultured human epidermal cells in the presence or absence of 
pemphigus IgG were similar. The majority of the PA activity comigrated with the 
higher-molecular-weight species of human urokinase (~55,000).  Explants of normal 
human  skin  incubated  with  pemphigus  vulgaris  IgG  displayed  loss  of epidermal 
cohesion similar  to that  observed in  patient  biopsies.  The histologic changes  were 
potentiated by the inclusion of human plasminogen.  Loss of epidermal cohesion in 
normal skin explants incubated with pemphigus foliaceous IgG was dependent upon 
the  addition  of plasminogen  and  was  inhibited by aprotinin  or lima bean  trypsin 
inhibitor, which indicated that plasmin is the active enzyme in producing acantholysis. 
These data support  the  hypothesis that  stimulation  of PA  by the  anti-cell surface 
autoantibodies of pemphigus results in a localized increase in plasmin, which through 
proteolysis produces the loss of epidermal cohesion characteristic of pemphigus. 
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